Tue.Dec 07, 2021

article thumbnail

Is artificial intelligence the best tool for drug discovery?

Outsourcing Pharma

According to a leader from Cytoreason, AI isnât necessarily the best or only tool suited to discover new and novel therapiesâit might take a human touch.

145
145
article thumbnail

With COVID-19 resurging, New York halts electives at 32 hospitals to preserve capacity

Fierce Healthcare

With COVID-19 resurging, New York halts electives at 32 hospitals to preserve capacity. dmuoio. Tue, 12/07/2021 - 15:03.

Hospitals 141
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mind the gap: Are you delivering what HCPs value or what you want them to have?

pharmaphorum

Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). In the age of information overload, we all know that it is essential to add ‘value’ if we are to cut through the noise. And therein lies an issue. In a recent study by EPG Health, pharma respondents voted ‘providing real value’ the top challenge (of 23) related to digital Health Care Provider (HCP) engagement.

article thumbnail

Centene to pay $27.6M to settle PBM investigation in Kansas

Fierce Healthcare

Centene to pay $27.6M to settle PBM investigation in Kansas. pminemyer. Tue, 12/07/2021 - 12:52.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

AZ gets closer to Ionis, licensing amyloidosis drug in $3.6bn deal

pharmaphorum

AstraZeneca has snapped up another Ionis-discovered drug for its pipeline, this time phase 3 candidate eplontersen for the disease transthyretin amyloidosis (ATTR). The deal is another sizeable one too, with an upfront fee of $200 million, another $485 million tied to regulatory approvals, and up to $2.9 billion in milestones depending on sales levels if the antisense-based drug reaches the market.

57
article thumbnail

House bill aims to delay 6% in Medicare cuts, postpones radiation oncology model

Fierce Healthcare

House bill aims to delay 6% in Medicare cuts, postpones radiation oncology model. rking. Tue, 12/07/2021 - 14:01.

134
134

More Trending

article thumbnail

Robin Healthcare lands $50M for its 'Alexa for healthcare' scribe device that takes over administrative tasks

Fierce Healthcare

Robin Healthcare lands $50M for its 'Alexa for healthcare' scribe device that takes over administrative tasks. rtorrence. Tue, 12/07/2021 - 10:15.

120
120
article thumbnail

Pharmaceutical Education Policy

Pharma Tutor

Pharmaceutical Education Policy. About Author. Dr. R. S. Thakur. Chief Editor. Journal of Pharmaceutical Research. Krupanidhi College of Pharmacy. Bengaluru-560035. admin. Tue, 12/07/2021 - 17:15. Tags. Articles.

52
article thumbnail

Voice-based clinical assistant Suki picks up $55M to fuel tech development, expand health system partnerships

Fierce Healthcare

Voice-based clinical assistant Suki picks up $55M to fuel tech development, expand health system partnerships. hlandi. Tue, 12/07/2021 - 14:54.

119
119
article thumbnail

EU approves Roche’s Actemra for severe COVID-19

pharmaphorum

The European Commission has moved swiftly to grant full approval to Roche’s Actemra/RoActemra as a treatment for severe COVID-19, clearing the drug within 24 hours of a recommendation from its advisory committee. Actemra (tocilizumab) has been approved for the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation, a group for which the drug is already available under emergency authorisations.

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Independence at Home payment model didn't yield significant savings, quality results for Medicare: study

Fierce Healthcare

Independence at Home payment model didn't yield significant savings, quality results for Medicare: study. rking. Tue, 12/07/2021 - 16:46.

111
111
article thumbnail

Merck halts more trials of HIV candidate islatravir

pharmaphorum

Merck & Co has halted enrolment in a pair of phase 3 trials of its experimental HIV drug islatravir, raising another warning flag about the highly-touted therapy. The two studies – IMPOWER 22 and IMPOWER 24 – are testing islatravir as a once-monthly, oral therapy for pre-exposure prophylaxis or PrEP, which accounts for a sizeable segment of the HIV drugs market.

FDA 52
article thumbnail

Female doctors earn an estimated $2M less than their male counterparts over a 40-year career: study

Fierce Healthcare

Female doctors earn an estimated $2M less than their male counterparts over a 40-year career: study. hlandi. Tue, 12/07/2021 - 11:18.

106
106
article thumbnail

Survey: research industry keen on DCT benefits, slow to adopt

Outsourcing Pharma

A survey on perceptions toward the decentralized clinical trial format, conducted by Climedo, shows the industry is aware of the benefits but faces barriers.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

United Health Foundation report: U.S. deaths rose 17% between 2019 and 2020

Fierce Healthcare

United Health Foundation report: U.S. deaths rose 17% between 2019 and 2020. agliadkovskaya. Tue, 12/07/2021 - 12:11.

111
111
article thumbnail

Trial tech can help strengthen human connections in research: Within3

Outsourcing Pharma

According to a leader from the virtual engagement solutions company, gaps in trial communications can be improved with the intelligent use of technology.

article thumbnail

Wisconsin hospitals filed 37% more lawsuits against patients from 2001 to 2018, study finds

Fierce Healthcare

Wisconsin hospitals filed 37% more lawsuits against patients from 2001 to 2018, study finds. dmuoio. Tue, 12/07/2021 - 12:07.

Hospitals 103
article thumbnail

Call To action Testing

Druggist

Get a Reliable Skin Numbing Cream. Available Alternative. Sulfonylurea. By subscribing, I consent to receiving emails. The post Call To action Testing appeared first on Druggist.Online.

52
article thumbnail

CMS to roll out 'birthing-friendly' hospital tag on Care Compare site

Fierce Healthcare

CMS to roll out 'birthing-friendly' hospital tag on Care Compare site. rking. Tue, 12/07/2021 - 15:43.

Hospitals 111
article thumbnail

CHMP recommend approval for Roche’s COVID-19 therapy

Pharma Times

According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients.

49
article thumbnail

U.S. News & World Report: The best hospitals for maternity care

Fierce Healthcare

U.S. News & World Report: The best hospitals for maternity care. agliadkovskaya. Tue, 12/07/2021 - 13:40.

article thumbnail

UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response

Pharma Times

Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.

article thumbnail

SEC charges American Renal Associates, former executives with revenue manipulation scheme

Fierce Healthcare

SEC charges American Renal Associates, former executives with revenue manipulation scheme. dmuoio. Tue, 12/07/2021 - 16:41.

59
article thumbnail

AI specialist Recursion nabs multibillion-dollar Roche partnership

pharmaphorum

Roche has formed a decade-long alliance with Recursion Pharma that will focus on using machine learning and “industrialised” drug discovery to find new neuroscience and cancer drugs. The Swiss drugmaker is paying $150 million upfront to kick off the strategic-level partnership, which could cover as many as 40 programmes and could be worth “several billion dollars”, according to Salt Lake City-based Recursion.

57
article thumbnail

Why Blockchain is the Best Technology for eSignatures in Healthcare

Fierce Healthcare

Why Blockchain is the Best Technology for eSignatures in Healthcare. admin. Tue, 12/07/2021 - 17:23.

52
article thumbnail

Viagra ‘should be tested as Alzheimer’s therapy’

pharmaphorum

Scientists in the US have found that people who use Viagra for erectile dysfunction seem to have a lower risk of developing Alzheimer’s disease – a link that they say should be examined more closely in clinical trials. Viagra (sildenafil) – originally developed by Pfizer – is now widely available as a generic and can even be bought from pharmacies over-the-counter in some countries.